Pfizer: Ulcerative Colitis (UC) Research
| Name: |
Pfizer: Ulcerative Colitis (UC) Research Application deadline: 12/09/23 |
|---|---|
| General description: |
Seeks to support global research that advances the role of Sphingosine-1-phosphate (S1P) receptor modulation in the treatment of UC. Funding: up to $200K for 18 months. www.pfizer.com/purpose/independent-grants/competitive-grants |
| Source: | Foreign |
| Participating Countries: | All Countries, |
| Budget: | up to $200K for 18 months. |
| Number of research years: | 18 months |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@technion.ac.ilRobi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@technion.ac.il; Orly, 1588, bakarev@trdf.technion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Pfizer ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |